Additionally, low expression of apoptosis-associated protein poly ADP-ribose polymerase (PARP) which reflects caspase 3 activity in the treated HCC cells also confirmed the existence of higher stiffness-mediated oxaliplatin resistance in HCC cells (Figure 1F). The gene discussed is CASP3; the disease is hepatocellular carcinoma.